| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -120 @ USD 105.88 | USD -12,706 | The ETF sold 120 shares of DVA on 2026-01-28. The shares were previously bought for an average price of USD 138.411. The DaVita HealthCare Partners Inc shares were sold for -23.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,904 The average price that the ETF previously sold DVA share for is USD 141.024 which is higher than the selling price of USD 105.88 on 2026-01-28. |
| HSIC - Henry Schein Inc | SELL | -348 @ USD 75.08 | USD -26,128 | The ETF sold 348 shares of HSIC on 2026-01-28. The shares were previously bought for an average price of USD 72.3113. The Henry Schein Inc shares were sold for 3.8% higher than average price of previous purchases. This sale made a profit of USD 964 The average price that the ETF previously sold HSIC share for is USD 70.1035 so the ETF has sold 348 shares on 2026-01-28 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -168 @ USD 187 | USD -31,416 | The ETF sold 168 shares of MOH on 2026-01-28. The shares were previously bought for an average price of USD 238.049. The MOH shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,576 The average price that the ETF previously sold MOH share for is USD 260.767 which is higher than the selling price of USD 187 on 2026-01-28. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -168 @ USD 187 | USD -31,416 | The ETF sold 168 shares of MOH on 2026-01-28. The shares were previously bought for an average price of USD 238.049. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -21.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,576 The average price that the ETF previously sold MOH share for is USD 260.767 which is higher than the selling price of USD 187 on 2026-01-28. |
| BAX - Baxter International Inc | SELL | -1,722 @ USD 19.61 | USD -33,768 | The ETF sold 1722 shares of BAX on 2026-01-28. The shares were previously bought for an average price of USD 26.752. The Baxter International Inc shares were sold for -26.7% lower than average price of previous purchases. This resulted in an overall loss of USD 12,299 The average price that the ETF previously sold BAX share for is USD 29.8457 which is higher than the selling price of USD 19.61 on 2026-01-28. |
| TECH - Bio-Techne Corp | SELL | -522 @ USD 65.56 | USD -34,222 | The ETF sold 522 shares of TECH on 2026-01-28. The shares were previously bought for an average price of USD 62.2663. The Bio-Techne Corp shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 1,719 The average price that the ETF previously sold TECH share for is USD 64.9738 so the ETF has sold 522 shares on 2026-01-28 at a higher price than the previous selling average. |
| CRL - Creightons Plc | SELL | -162 @ USD 216.88 | USD -35,135 | The ETF sold 162 shares of CRL on 2026-01-28. The shares were previously bought for an average price of USD 174.212. The Creightons Plc shares were sold for 24.5% higher than average price of previous purchases. This sale made a profit of USD 6,912 The average price that the ETF previously sold CRL share for is USD 175.645 so the ETF has sold 162 shares on 2026-01-28 at a higher price than the previous selling average. |
| UHS - Universal Health Services Inc | SELL | -180 @ USD 203.02 | USD -36,544 | The ETF sold 180 shares of UHS on 2026-01-28. The shares were previously bought for an average price of USD 201.208. The Universal Health Services Inc shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 326 The average price that the ETF previously sold UHS share for is USD 200.711 so the ETF has sold 180 shares on 2026-01-28 at a higher price than the previous selling average. |
| ALGN - Align Technology Inc | SELL | -222 @ USD 164.92 | USD -36,612 | The ETF sold 222 shares of ALGN on 2026-01-28. The shares were previously bought for an average price of USD 170.079. The Align Technology Inc shares were sold for -3.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,145 The average price that the ETF previously sold ALGN share for is USD 195.687 which is higher than the selling price of USD 164.92 on 2026-01-28. |
| SOLV - Solventum Corp. | SELL | -492 @ USD 76.6 | USD -37,687 | The ETF sold 492 shares of SOLV on 2026-01-28. The shares were previously bought for an average price of USD 75.4386. The Solventum Corp. shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 571 The average price that the ETF previously sold SOLV share for is USD 73.5554 so the ETF has sold 492 shares on 2026-01-28 at a higher price than the previous selling average. |
| RVTY - Revvity Inc. | SELL | -378 @ USD 111.13 | USD -42,007 | The ETF sold 378 shares of RVTY on 2026-01-28. The shares were previously bought for an average price of USD 104.85. The Revvity Inc. shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 2,374 The average price that the ETF previously sold RVTY share for is USD 105.367 so the ETF has sold 378 shares on 2026-01-28 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -3,870 @ USD 12.97 | USD -50,194 | The ETF sold 3870 shares of VTRS on 2026-01-28. The shares were previously bought for an average price of USD 10.5928. The Viatris Inc shares were sold for 22.4% higher than average price of previous purchases. This sale made a profit of USD 9,200 The average price that the ETF previously sold VTRS share for is USD 11.0295 so the ETF has sold 3870 shares on 2026-01-28 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -264 @ USD 194.01 | USD -51,219 | The ETF sold 264 shares of HUM on 2026-01-28. The shares were previously bought for an average price of USD 264.042. The Hummingbird Resources PLC shares were sold for -26.5% lower than average price of previous purchases. This resulted in an overall loss of USD 18,488 The average price that the ETF previously sold HUM share for is USD 268.812 which is higher than the selling price of USD 194.01 on 2026-01-28. |
| HUM - Humana Inc | SELL | -264 @ USD 194.01 | USD -51,219 | The ETF sold 264 shares of HUM on 2026-01-28. The shares were previously bought for an average price of USD 264.042. The Humana Inc shares were sold for -26.5% lower than average price of previous purchases. This resulted in an overall loss of USD 18,488 The average price that the ETF previously sold HUM share for is USD 268.812 which is higher than the selling price of USD 194.01 on 2026-01-28. |
| MRNA - Moderna Inc | SELL | -1,152 @ USD 45.3 | USD -52,186 | The ETF sold 1152 shares of MRNA on 2026-01-28. The shares were previously bought for an average price of USD 31.769. The Moderna Inc shares were sold for 42.6% higher than average price of previous purchases. This sale made a profit of USD 15,588 The average price that the ETF previously sold MRNA share for is USD 36.2864 so the ETF has sold 1152 shares on 2026-01-28 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -672 @ USD 80.48 | USD -54,083 | The ETF sold 672 shares of COO on 2026-01-28. The shares were previously bought for an average price of USD 81.8211. The The Cooper Companies, Inc. Common Stock shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 901 The average price that the ETF previously sold COO share for is USD 87.883 which is higher than the selling price of USD 80.48 on 2026-01-28. |
| INCY - Incyte Corporation | SELL | -552 @ USD 101.18 | USD -55,851 | The ETF sold 552 shares of INCY on 2026-01-28. The shares were previously bought for an average price of USD 82.2056. The Incyte Corporation shares were sold for 23.1% higher than average price of previous purchases. This sale made a profit of USD 10,474 The average price that the ETF previously sold INCY share for is USD 77.8831 so the ETF has sold 552 shares on 2026-01-28 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -744 @ USD 75.1 | USD -55,874 | The ETF sold 744 shares of HOLX on 2026-01-28. The shares were previously bought for an average price of USD 69.5119. The Hologic Inc shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 4,158 The average price that the ETF previously sold HOLX share for is USD 71.0767 so the ETF has sold 744 shares on 2026-01-28 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -240 @ USD 235.89 | USD -56,614 | The ETF sold 240 shares of WST on 2026-01-28. The shares were previously bought for an average price of USD 263.236. The West Pharmaceutical Services Inc shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,563 The average price that the ETF previously sold WST share for is USD 277.988 which is higher than the selling price of USD 235.89 on 2026-01-28. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -666 @ USD 85.71 | USD -57,083 | The ETF sold 666 shares of ZBH on 2026-01-28. The shares were previously bought for an average price of USD 99.8199. The Zimmer Biomet Holdings Inc shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 9,397 The average price that the ETF previously sold ZBH share for is USD 102.546 which is higher than the selling price of USD 85.71 on 2026-01-28. |
| PODD - Insulet Corporation | SELL | -234 @ USD 258.2 | USD -60,419 | The ETF sold 234 shares of PODD on 2026-01-28. The shares were previously bought for an average price of USD 291.26. The Insulet Corporation shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 7,736 The average price that the ETF previously sold PODD share for is USD 280.939 which is higher than the selling price of USD 258.2 on 2026-01-28. |
| CNC - Concurrent Technologies Plc | SELL | -1,566 @ USD 41.9 | USD -65,615 | The ETF sold 1566 shares of CNC on 2026-01-28. The shares were previously bought for an average price of USD 49.0792. The Concurrent Technologies Plc shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of USD 11,243 The average price that the ETF previously sold CNC share for is USD 50.2168 which is higher than the selling price of USD 41.9 on 2026-01-28. |
| DGX - Quest Diagnostics Incorporated | SELL | -378 @ USD 182.74 | USD -69,076 | The ETF sold 378 shares of DGX on 2026-01-28. The shares were previously bought for an average price of USD 175.456. The Quest Diagnostics Incorporated shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 2,753 The average price that the ETF previously sold DGX share for is USD 168.913 so the ETF has sold 378 shares on 2026-01-28 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -276 @ USD 268.04 | USD -73,979 | The ETF sold 276 shares of LH on 2026-01-28. The shares were previously bought for an average price of USD 256.114. The Laboratory Corporation of America Holdings shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 3,292 The average price that the ETF previously sold LH share for is USD 246.813 so the ETF has sold 276 shares on 2026-01-28 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -198 @ USD 385.03 | USD -76,236 | The ETF sold 198 shares of WAT on 2026-01-28. The shares were previously bought for an average price of USD 365.178. The Waters Corporation shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 3,931 The average price that the ETF previously sold WAT share for is USD 366.2 so the ETF has sold 198 shares on 2026-01-28 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -198 @ USD 385.03 | USD -76,236 | The ETF sold 198 shares of WAT on 2026-01-28. The shares were previously bought for an average price of USD 365.178. The MULETFWATIMETFP shares were sold for 5.4% higher than average price of previous purchases. This sale made a profit of USD 3,931 The average price that the ETF previously sold WAT share for is USD 366.2 so the ETF has sold 198 shares on 2026-01-28 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -486 @ USD 174.83 | USD -84,967 | The ETF sold 486 shares of BIIB on 2026-01-28. The shares were previously bought for an average price of USD 151.824. The Biogen Inc shares were sold for 15.2% higher than average price of previous purchases. This sale made a profit of USD 11,181 The average price that the ETF previously sold BIIB share for is USD 154.621 so the ETF has sold 486 shares on 2026-01-28 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -330 @ USD 260.86 | USD -86,084 | The ETF sold 330 shares of STE on 2026-01-28. The shares were previously bought for an average price of USD 238.806. The STERIS plc shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 7,278 The average price that the ETF previously sold STE share for is USD 229.729 so the ETF has sold 330 shares on 2026-01-28 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -66 @ USD 1401.64 | USD -92,508 | The ETF sold 66 shares of MTD on 2026-01-28. The shares were previously bought for an average price of USD 1315.16. The Mettler-Toledo International Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 5,708 The average price that the ETF previously sold MTD share for is USD 1267.75 so the ETF has sold 66 shares on 2026-01-28 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -66 @ USD 1401.64 | USD -92,508 | The ETF sold 66 shares of MTD on 2026-01-28. The shares were previously bought for an average price of USD 1315.16. The AMUNDI EUR GOV 710 shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 5,708 The average price that the ETF previously sold MTD share for is USD 1267.75 so the ETF has sold 66 shares on 2026-01-28 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -1,308 @ USD 73.36 | USD -95,955 | The ETF sold 1308 shares of DXCM on 2026-01-28. The shares were previously bought for an average price of USD 72.3142. The DexCom Inc shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 1,368 The average price that the ETF previously sold DXCM share for is USD 75.1656 which is higher than the selling price of USD 73.36 on 2026-01-28. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,512 @ USD 79.26 | USD -119,841 | The ETF sold 1512 shares of GEHC on 2026-01-28. The shares were previously bought for an average price of USD 80.6074. The GE HealthCare Technologies Inc. shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,037 The average price that the ETF previously sold GEHC share for is USD 79.5695 which is higher than the selling price of USD 79.26 on 2026-01-28. |
| RMD - ResMed Inc | SELL | -486 @ USD 257.72 | USD -125,252 | The ETF sold 486 shares of RMD on 2026-01-28. The shares were previously bought for an average price of USD 247.779. The ResMed Inc shares were sold for 4.0% higher than average price of previous purchases. This sale made a profit of USD 4,831 The average price that the ETF previously sold RMD share for is USD 247.789 so the ETF has sold 486 shares on 2026-01-28 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -942 @ USD 133.87 | USD -126,106 | The ETF sold 942 shares of A on 2026-01-28. The shares were previously bought for an average price of USD 134.493. The Agilent Technologies Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 587 The average price that the ETF previously sold A share for is USD 132.023 so the ETF has sold 942 shares on 2026-01-28 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -570 @ USD 239.76 | USD -136,663 | The ETF sold 570 shares of IQV on 2026-01-28. The shares were previously bought for an average price of USD 200.991. The IQVIA Holdings Inc shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of USD 22,098 The average price that the ETF previously sold IQV share for is USD 193.166 so the ETF has sold 570 shares on 2026-01-28 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -1,932 @ USD 81.86 | USD -158,154 | The ETF sold 1932 shares of EW on 2026-01-28. The shares were previously bought for an average price of USD 76.1739. The Edwards Lifesciences Corp shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 10,986 The average price that the ETF previously sold EW share for is USD 73.8861 so the ETF has sold 1932 shares on 2026-01-28 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -786 @ USD 210.39 | USD -165,367 | The ETF sold 786 shares of CAH on 2026-01-28. The shares were previously bought for an average price of USD 159.417. The Cardinal Health Inc shares were sold for 32.0% higher than average price of previous purchases. This sale made a profit of USD 40,065 The average price that the ETF previously sold CAH share for is USD 146.063 so the ETF has sold 786 shares on 2026-01-28 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -1,470 @ USD 121.93 | USD -179,237 | The ETF sold 1470 shares of ZTS on 2026-01-28. The shares were previously bought for an average price of USD 148.308. The Zoetis Inc shares were sold for -17.8% lower than average price of previous purchases. This resulted in an overall loss of USD 38,776 The average price that the ETF previously sold ZTS share for is USD 161.775 which is higher than the selling price of USD 121.93 on 2026-01-28. |
| IDXX - IDEXX Laboratories Inc | SELL | -264 @ USD 687.74 | USD -181,563 | The ETF sold 264 shares of IDXX on 2026-01-28. The shares were previously bought for an average price of USD 572.22. The IDEXX Laboratories Inc shares were sold for 20.2% higher than average price of previous purchases. This sale made a profit of USD 30,497 The average price that the ETF previously sold IDXX share for is USD 506.723 so the ETF has sold 264 shares on 2026-01-28 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -954 @ USD 201.92 | USD -192,632 | The ETF sold 954 shares of BDX on 2026-01-28. The shares were previously bought for an average price of USD 206.175. The Becton Dickinson and Company shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,059 The average price that the ETF previously sold BDX share for is USD 206.112 which is higher than the selling price of USD 201.92 on 2026-01-28. |
| COR - Cencora Inc. | SELL | -642 @ USD 350.54 | USD -225,047 | The ETF sold 642 shares of COR on 2026-01-28. The shares were previously bought for an average price of USD 306.125. The Cencora Inc. shares were sold for 14.5% higher than average price of previous purchases. This sale made a profit of USD 28,514 The average price that the ETF previously sold COR share for is USD 279.722 so the ETF has sold 642 shares on 2026-01-28 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -888 @ USD 272.38 | USD -241,873 | The ETF sold 888 shares of CI on 2026-01-28. The shares were previously bought for an average price of USD 295.977. The Cigna Corp shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of USD 20,954 The average price that the ETF previously sold CI share for is USD 311.205 which is higher than the selling price of USD 272.38 on 2026-01-28. |
| ELV - Elevance Health Inc | SELL | -738 @ USD 341.85 | USD -252,285 | The ETF sold 738 shares of ELV on 2026-01-28. The shares were previously bought for an average price of USD 372.682. The Elevance Health Inc shares were sold for -8.3% lower than average price of previous purchases. This resulted in an overall loss of USD 22,754 The average price that the ETF previously sold ELV share for is USD 385.937 which is higher than the selling price of USD 341.85 on 2026-01-28. |
| ELV - Elevance Health Inc | SELL | -738 @ USD 341.85 | USD -252,285 | The ETF sold 738 shares of ELV on 2026-01-28. The shares were previously bought for an average price of USD 372.682. The Elevance Health Inc shares were sold for -8.3% lower than average price of previous purchases. This resulted in an overall loss of USD 22,754 The average price that the ETF previously sold ELV share for is USD 385.937 which is higher than the selling price of USD 341.85 on 2026-01-28. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -336 @ USD 751.13 | USD -252,380 | The ETF sold 336 shares of REGN on 2026-01-28. The shares were previously bought for an average price of USD 680.49. The Regeneron Pharmaceuticals Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 23,735 The average price that the ETF previously sold REGN share for is USD 690.415 so the ETF has sold 336 shares on 2026-01-28 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -528 @ USD 491.23 | USD -259,369 | The ETF sold 528 shares of HCA on 2026-01-28. The shares were previously bought for an average price of USD 399.739. The HCA Holdings Inc shares were sold for 22.9% higher than average price of previous purchases. This sale made a profit of USD 48,307 The average price that the ETF previously sold HCA share for is USD 381.406 so the ETF has sold 528 shares on 2026-01-28 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -4,218 @ USD 74.03 | USD -312,259 | The ETF sold 4218 shares of CVS on 2026-01-28. The shares were previously bought for an average price of USD 71.0303. The CVS Health Corp shares were sold for 4.2% higher than average price of previous purchases. This sale made a profit of USD 12,653 The average price that the ETF previously sold CVS share for is USD 63.8671 so the ETF has sold 4218 shares on 2026-01-28 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -408 @ USD 826.62 | USD -337,261 | The ETF sold 408 shares of MCK on 2026-01-28. The shares were previously bought for an average price of USD 725.736. The McKesson Corporation shares were sold for 13.9% higher than average price of previous purchases. This sale made a profit of USD 41,161 The average price that the ETF previously sold MCK share for is USD 679.922 so the ETF has sold 408 shares on 2026-01-28 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,762 @ USD 54.62 | USD -369,340 | The ETF sold 6762 shares of BMY on 2026-01-28. The shares were previously bought for an average price of USD 52.5619. The Bloomsbury Publishing Plc shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 13,917 The average price that the ETF previously sold BMY share for is USD 53.0586 so the ETF has sold 6762 shares on 2026-01-28 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -840 @ USD 477.91 | USD -401,444 | The ETF sold 840 shares of VRTX on 2026-01-28. The shares were previously bought for an average price of USD 448.465. The Vertex Pharmaceuticals Inc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 24,734 The average price that the ETF previously sold VRTX share for is USD 464.932 so the ETF has sold 840 shares on 2026-01-28 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,140 @ USD 357.83 | USD -407,926 | The ETF sold 1140 shares of SYK on 2026-01-28. The shares were previously bought for an average price of USD 371.583. The Stryker Corporation shares were sold for -3.7% lower than average price of previous purchases. This resulted in an overall loss of USD 15,678 The average price that the ETF previously sold SYK share for is USD 378.113 which is higher than the selling price of USD 357.83 on 2026-01-28. |
| MDT - Medtronic PLC | SELL | -4,254 @ USD 100.79 | USD -428,761 | The ETF sold 4254 shares of MDT on 2026-01-28. The shares were previously bought for an average price of USD 92.8233. The Medtronic PLC shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of USD 33,890 The average price that the ETF previously sold MDT share for is USD 89.0355 so the ETF has sold 4254 shares on 2026-01-28 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -4,920 @ USD 93.79 | USD -461,447 | The ETF sold 4920 shares of BSX on 2026-01-28. The shares were previously bought for an average price of USD 98.1663. The Boston Scientific Corporation shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 21,531 The average price that the ETF previously sold BSX share for is USD 94.9669 which is higher than the selling price of USD 93.79 on 2026-01-28. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,920 @ USD 93.79 | USD -461,447 | The ETF sold 4920 shares of BSX on 2026-01-28. The shares were previously bought for an average price of USD 98.1663. The MULSTRXSSXIMETFP shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 21,531 The average price that the ETF previously sold BSX share for is USD 94.9669 which is higher than the selling price of USD 93.79 on 2026-01-28. |
| DHR - Danaher Corporation | SELL | -2,082 @ USD 224.54 | USD -467,492 | The ETF sold 2082 shares of DHR on 2026-01-28. The shares were previously bought for an average price of USD 217.488. The Danaher Corporation shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 14,682 The average price that the ETF previously sold DHR share for is USD 223.256 so the ETF has sold 2082 shares on 2026-01-28 at a higher price than the previous selling average. |
| DHR - Danaher Corporation | SELL | -2,082 @ USD 224.54 | USD -467,492 | The ETF sold 2082 shares of DHR on 2026-01-28. The shares were previously bought for an average price of USD 217.488. The Danaher Corporation shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 14,682 The average price that the ETF previously sold DHR share for is USD 223.256 so the ETF has sold 2082 shares on 2026-01-28 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -18,864 @ USD 25.86 | USD -487,823 | The ETF sold 18864 shares of PFE on 2026-01-28. The shares were previously bought for an average price of USD 25.4746. The Pfizer Inc shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 7,270 The average price that the ETF previously sold PFE share for is USD 25.382 so the ETF has sold 18864 shares on 2026-01-28 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -4,116 @ USD 139.72 | USD -575,088 | The ETF sold 4116 shares of GILD on 2026-01-28. The shares were previously bought for an average price of USD 112.082. The Guild Esports Plc shares were sold for 24.7% higher than average price of previous purchases. This sale made a profit of USD 113,758 The average price that the ETF previously sold GILD share for is USD 103.58 so the ETF has sold 4116 shares on 2026-01-28 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,782 @ USD 342.22 | USD -609,836 | The ETF sold 1782 shares of AMGN on 2026-01-28. The shares were previously bought for an average price of USD 308.061. The Amgen Inc shares were sold for 11.1% higher than average price of previous purchases. This sale made a profit of USD 60,871 The average price that the ETF previously sold AMGN share for is USD 299.526 so the ETF has sold 1782 shares on 2026-01-28 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -5,766 @ USD 106.05 | USD -611,484 | The ETF sold 5766 shares of ABT on 2026-01-28. The shares were previously bought for an average price of USD 127.645. The Abbott Laboratories shares were sold for -16.9% lower than average price of previous purchases. This resulted in an overall loss of USD 124,517 The average price that the ETF previously sold ABT share for is USD 123.493 which is higher than the selling price of USD 106.05 on 2026-01-28. |
| ISRG - Intuitive Surgical Inc | SELL | -1,176 @ USD 522.04 | USD -613,919 | The ETF sold 1176 shares of ISRG on 2026-01-28. The shares were previously bought for an average price of USD 529.25. The Intuitive Surgical Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 8,479 The average price that the ETF previously sold ISRG share for is USD 533.797 which is higher than the selling price of USD 522.04 on 2026-01-28. |
| TMO - Time Out Group plc | SELL | -1,242 @ USD 608.02 | USD -755,161 | The ETF sold 1242 shares of TMO on 2026-01-28. The shares were previously bought for an average price of USD 535.339. The Time Out Group plc shares were sold for 13.6% higher than average price of previous purchases. This sale made a profit of USD 90,270 The average price that the ETF previously sold TMO share for is USD 508.129 so the ETF has sold 1242 shares on 2026-01-28 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -8,238 @ USD 106.9 | USD -880,642 | The ETF sold 8238 shares of MRK on 2026-01-28. The shares were previously bought for an average price of USD 92.5956. The Marks Electrical Group PLC shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of USD 117,840 The average price that the ETF previously sold MRK share for is USD 94.2103 so the ETF has sold 8238 shares on 2026-01-28 at a higher price than the previous selling average. |
| MRK - Merck & Company Inc | SELL | -8,238 @ USD 106.9 | USD -880,642 | The ETF sold 8238 shares of MRK on 2026-01-28. The shares were previously bought for an average price of USD 92.5956. The Merck & Company Inc shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of USD 117,840 The average price that the ETF previously sold MRK share for is USD 94.2103 so the ETF has sold 8238 shares on 2026-01-28 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,000 @ USD 294.02 | USD -882,060 | The ETF sold 3000 shares of UNH on 2026-01-28. The shares were previously bought for an average price of USD 413.396. The UnitedHealth Group Incorporated shares were sold for -28.9% lower than average price of previous purchases. This resulted in an overall loss of USD 358,128 The average price that the ETF previously sold UNH share for is USD 462.311 which is higher than the selling price of USD 294.02 on 2026-01-28. |
| ABBV - AbbVie Inc | SELL | -5,856 @ USD 218.67 | USD -1,280,532 | The ETF sold 5856 shares of ABBV on 2026-01-28. The shares were previously bought for an average price of USD 208.619. The AbbVie Inc shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 58,859 The average price that the ETF previously sold ABBV share for is USD 194.592 so the ETF has sold 5856 shares on 2026-01-28 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -7,980 @ USD 227.72 | USD -1,817,206 | The ETF sold 7980 shares of JNJ on 2026-01-28. The shares were previously bought for an average price of USD 178.664. The Johnson & Johnson shares were sold for 27.5% higher than average price of previous purchases. This sale made a profit of USD 391,467 The average price that the ETF previously sold JNJ share for is USD 164.193 so the ETF has sold 7980 shares on 2026-01-28 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -2,628 @ USD 1023.8 | USD -2,690,546 | The ETF sold 2628 shares of LLY on 2026-01-28. The shares were previously bought for an average price of USD 887.237. The Eli Lilly and Company shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of USD 358,888 The average price that the ETF previously sold LLY share for is USD 831.268 so the ETF has sold 2628 shares on 2026-01-28 at a higher price than the previous selling average. |